BUZZ-AstraZeneca top loser on FTSE 100 after heart disease drug fails late-stage trial

AstraZeneca PLC
Ionis Pharmaceuticals, Inc.

AstraZeneca PLC

AZN

0.00

Ionis Pharmaceuticals, Inc.

IONS

0.00

** Shares of AstraZeneca AZN.L slump as much as 9.6% to 12,874p; on track for their worst day since 2017

** AZN is top loser on FTSE 100 .FTSE index, which is down 0.4%

** Co says its nerve disease drug Wainua, made in partnership with Ionis IONS.O, failed to meet main goal of reducing cardiovascular deaths & recurring heart problems in a late-stage trial

** AZN down 6% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.